<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">J Exp Clin Cancer Res</journal-id><journal-title>Journal of Experimental &#x00026; Clinical Cancer Research : CR</journal-title><issn pub-type="ppub">0392-9078</issn><issn pub-type="epub">1756-9966</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1756-9966-28-37</article-id><article-id pub-id-type="pmid">19284666</article-id><article-id pub-id-type="doi">10.1186/1756-9966-28-37</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Genetic polymorphisms in DNA base excision repair gene <italic>XRCC1 </italic>and the risk of squamous cell carcinoma of the head and neck</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Kowalski</surname><given-names>Michal</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>zabiakow@o2.pl</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Przybylowska</surname><given-names>Karolina</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>tonina1@wp.pl</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Rusin</surname><given-names>Pawel</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>pawelrusin@gmail.com</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Olszewski</surname><given-names>Jurek</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>jolsz@imp.lodz.pl</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Morawiec-Sztandera</surname><given-names>Alina</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>morawiec@csk.am.lodz.pl</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Bielecka-Kowalska</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>zabiakow@o2.pl</email></contrib><contrib id="A7" contrib-type="author"><name><surname>Pietruszewska</surname><given-names>Wioletta</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>pietruszewska@op.pl</email></contrib><contrib id="A8" contrib-type="author"><name><surname>Mlynarski</surname><given-names>Wojciech</given-names></name><xref ref-type="aff" rid="I6">6</xref><email>Wojciech.Mlynarski@joslin.harvard.edu</email></contrib><contrib id="A9" contrib-type="author"><name><surname>Szemraj</surname><given-names>Janusz</given-names></name><xref ref-type="aff" rid="I7">7</xref><email>jszemraj@csk.am.lodz.pl</email></contrib><contrib id="A10" corresp="yes" contrib-type="author"><name><surname>Majsterek</surname><given-names>Ireneusz</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>imajst@biol.uni.lodz.pl</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Chronopharmacology, Medical University of Lodz, Lodz, Poland</aff><aff id="I2"><label>2</label>Department of Molecular Genetics, University of Lodz, Lodz, Poland</aff><aff id="I3"><label>3</label>Department of Otolaryngology and Oncology, Medical University of Lodz, Lodz, Poland</aff><aff id="I4"><label>4</label>Department of Head and Neck Cancer, Medical University of Lodz, Lodz, Poland</aff><aff id="I5"><label>5</label>Department of Otolaryngology, Medical University of Lodz, Lodz, Poland</aff><aff id="I6"><label>6</label>Department of Pediatrics, Medical University of Lodz, Lodz, Poland</aff><aff id="I7"><label>7</label>Department of Medical Biochemistry, Medical University of Lodz, Lodz, Poland</aff><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>13</day><month>3</month><year>2009</year></pub-date><volume>28</volume><issue>1</issue><fpage>37</fpage><lpage>37</lpage><ext-link ext-link-type="uri" xlink:href="http://www.jeccr.com/content/28/1/37"/><history><date date-type="received"><day>8</day><month>12</month><year>2008</year></date><date date-type="accepted"><day>13</day><month>3</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 Kowalski et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>Kowalski et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Kowalski Michal zabiakow@o2.pl </dc:author><dc:title> Genetic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neck </dc:title><dc:date>2009</dc:date><dcterms:bibliographicCitation>Journal of Experimental &#x00026; Clinical Cancer Research 28(1): 37-. (2009)</dcterms:bibliographicCitation><dc:identifier type="sici">1756-9966(2009)28:1&#x0003c;37&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1756-9966</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>The genes of base excision repair (BER) pathway have been extensively studied in the association with various human cancers. We performed a case-control study to test the association between two common single nucleotide polymorphisms (SNPs) of <italic>XRCC1 </italic>gene with human head and neck squamous cell carcinoma (HNSCC).</p></sec><sec sec-type="methods"><title>Methods</title><p>The genotype analysis of Arg194Trp and Arg399Gln gene polymorphisms for 92 HNSCC patients and 124 controls of cancer free subjects, in Polish population were performed using the PCR-based restriction fragment length polymorphism (PCR-RFLP) with endonuclease <italic>Msp</italic>I.</p></sec><sec><title>Results</title><p>No altered risk has been found individually for these SNPs, however haplotypes analysis showed high association with head and neck cancer. The highest frequency, according to wild-type of Arg194Arg and Arg399Arg genotypes, was identified for Arg194Trp-Arg399Arg haplotype (OR, 2.96; 95% CI, 1.01&#x02013;8.80).</p></sec><sec><title>Conclusion</title><p>Finally, we identified the combined Arg194Trp-Arg399Arg genotype of base excision repair gene <italic>XRCC1 </italic>that was associated with HNSCC and may have an impact on identification of a high-risk cancer population.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Genome integrity is maintained by an intricate network of DNA repair proteins [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. Organisms have developed several DNA repair pathways as well as DNA damage checkpoints. Although each pathway is addressed individually, the cross talk exists between repair pathways, and there are instances in which a DNA-repair protein is involved in more than one pathway. Single nucleotide polymorphisms (SNPs) in DNA repair genes may be associated with differences in the repair efficiency of DNA damage and may influence an individual's risk of cancer. Establishing this connection, however, has been a challenge due to the complexity of interactions that affect the repair pathways [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. Increasing evidence links environmental exposures, subtle modification in DNA repair efficiency, and cancer risk [<xref ref-type="bibr" rid="B5">5</xref>].</p><p>The genes belonging to base excision repair (BER) pathway, such as X-ray Repair Cross Complementing Group 1 (<italic>XRCC1</italic>) have been extensively studied in the association with various human cancer [<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B14">14</xref>]. Two major SNPs of the <italic>XRCC1 </italic>gene have been identified at codon 194 (C &#x0003e; T substitution at position 26304, exon 6, Arg to Trp) and 399 (G &#x0003e; A substitution at position 28152, exon 10, Arg to Gln). The <italic>XRCC1 </italic>Arg399Gln polymorphism is located in the area coding for a PARP binding site. PARP is a zinc-fnger containing enzyme that detects DNA strand breaks [<xref ref-type="bibr" rid="B15">15</xref>]. Carriers of the <italic>XRCC</italic>1 399 Gln variant allele have been shown to have higher levels of DNA adducts [<xref ref-type="bibr" rid="B16">16</xref>] and to be at greater risk for ionizing radiation sensitivity [<xref ref-type="bibr" rid="B17">17</xref>] and tobacco correlated DNA damage [<xref ref-type="bibr" rid="B18">18</xref>-<xref ref-type="bibr" rid="B20">20</xref>].</p><p>The XRCC1 protein plays an important role in the maintenance of genomic stability through the both base excision and single-strand break repair by acting as a scaffold for other DNA repair proteins, such as DNA glycosylases, polymerase beta [<xref ref-type="bibr" rid="B21">21</xref>] and ligase III [<xref ref-type="bibr" rid="B22">22</xref>]. XRCC1 participates in the first step of BER by interacting with the numerous of human DNA glycosylases including hOGG1, MPG, hNTH1 and NEIL1 [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>]. It was found that XRCC1, through its NTD and BRCT1 domains, has affinity to form a covalent complex via Schiff base with AP sites. It was also reported that XRCC1 affinity was higher when the DNA carried an AP-lyase- or APE1-incised AP site [<xref ref-type="bibr" rid="B25">25</xref>]. This results in an acceleration of the overall repair process of abasic site, which can be used as a substrate by DNA polymerase beta. Thus, this suggests mechanism by which XRCC1, through its multiple protein-protein interactions plays essential role in the resealing of the repaired DNA strand.</p><p>Head and neck squamous cell carcinoma (HNSCC) comprise about 6% of all malignant neoplasm. Overall survival is low especially in developing countries and the major risk factors of HNSCC became smoking or alcohol consumption [<xref ref-type="bibr" rid="B26">26</xref>]. Although the functional significance of XRCC1 polymorphism has not yet been fully elucidated, due to smoking and alcohol consumption attitude it may increase risk of head and neck cancer occurrence [<xref ref-type="bibr" rid="B27">27</xref>]. To test this hypothesis, we performed a hospital based case-control study using a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay to genotype two polymorphisms of DNA repair gene <italic>XRCC1 </italic>Arg194Trp and Arg399Gln in relation to head and neck cancer susceptibility.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Patients</title><p>Blood samples were obtained from 92 patients (50 men and 42 women, mean age 48.7 &#x000b1; 11.13) with squamous carcinoma of head and neck. Control samples consisted of age matched 124 cancer-free blood donors (63 men and 61 women, mean age 44.47 &#x000b1; 19.24). Despite of 4 years younger controls then patients, there were not statistical differences in age of analyzed groups (P = 0.169). Prior to examination, the patients and control subjects, did not receive medicaments like antibiotics or steroids. Patients enrolled to the examination were analyzed according to cancer staging system of the TNM Classification of Malignant Tumours that describes the extent of cancer in a patient's body: T describes the size of the tumor and whether it has invaded nearby tissue, N describes regional lymph nodes that are involved and M describes distant metastasis (spread of cancer from one body part to another). Within the control group selected subjects (52 cases) were classified as smokers for at least 10 years, up to 10 cigarettes per day. The smoking attitude of head and neck cancer group was also analyzed for non-smoking patients, patients smoking 10 cigarettes per day for ten years, patients smoking 20 cigarettes per day for twenty years and patients smoking 20 cigarettes per day for thirty years. All patients and controls subjects were recruited from three medical units of Head and Neck Neoplasm Surgery Departments, Medical University of Lodz, Poland. All subjects included into the study were unrelated Caucasians and inhibited Lodz district, Poland. The study was approved by the Local Ethic Committee and written consent was obtained from each patient or healthy blood donor before enrolling into the study.</p></sec><sec><title>Genotype determination</title><p>Genomic DNA was isolated from blood cells using Phenol-Chloroform extraction method. Genotypic analysis of the <italic>XRCC1 </italic>399 G &#x0003e; A polymorphism was determined by the PCR-based restriction fragment length polymorphism (PCR-RFLP) method, as described in detail earlier [<xref ref-type="bibr" rid="B28">28</xref>]. Briefly, PCR primers for the <italic>XRCC1 </italic>codon 194 (forward 5'-GCCCCGTCCCAGGTA-3' and reverse 5'-AGCCCCAAGACCCTTTCATC-3') were used to generate a 292 bp product containing the polymorphic sites. PCR primers for the <italic>XRCC1 </italic>codon 399 (forward 5'-TTGTGCTTTCTCTGTGTCCA-3' and reverse 5'-TCCTCCAGCCTTTTCTGATA-3') were used to generate a 615 bp product containing the polymorphic sites. The PCR was carried out in a MJ Research, INC thermal cycler, model PTC-100 (Waltham, MA, USA). The PCR reactions were carried out in a 20 &#x003bc;l volume of 20 pmol of each primer, 0.2 mM each dNTP and 1 &#x003bc;l buffer and 1 U of <italic>Taq </italic>polymerase, with a denaturation of 94&#x000b0;C for 5 min, followed by 30 cycles of 30 s at 61&#x000b0;C and 45 s at 72&#x000b0;C and finally 7 min at 72&#x000b0;C. Following amplification, PCR products were digested using 10 U of restriction enzyme <italic>Msp</italic>I (New England BioLabs, Beverly, MA, USA) for 16 h at 37&#x000b0;C, and electrophoresed on a 3% agarose gel. The wild type Arg allele for codon 194 is determined by the presence of a band at 292 bp, while the mutant Trp allele is determined by the presence of a band at 313 bp (indicative of the absence of the <italic>Msp</italic>I cutting site). In addition to these bands, a 174 bp band, resulting from an additional invariant cutting site for <italic>Msp</italic>I in the 491 bp amplified fragment (codon 194) is always present and serves as internal control for complete <italic>Msp</italic>I digestion. The wild type Arg allele for codon 399 is determined by the presence of two bands at 374 and 221 bp, while the mutant Gln allele is determined by the presence of the uncut 615 bp band (indicative of the absence of the <italic>Msp</italic>I cutting site).</p></sec><sec><title>Data analysis</title><p>The allelic frequencies were estimated by gene counting and genotypes were scored. The &#x003c7;<sup>2 </sup>test was used to compare the observed numbers of genotypes with those expected for a population in the Hardy-Weinberg equilibrium and to test the significance of the differences of observed alleles and genotypes between groups. The odds ratios (ORs) and 95% confidence intervals (CIs) were calculated by using a logistic regression model. The t-test (for normal distribution) or Manne-Whitney test (for non-normal distribution) was used to compare each parameter between two groups (i.e. sex and age). An analysis of variance test was used to identify parameters that would make significant differences between more than two groups; Scheffe's test was then used to assess the significance of difference in each identified parameter between any two groups. STATISTICA 6.0 software (Statsoft, Tulsa, OK, USA) was used to perform analyses.</p></sec></sec><sec><title>Results and discussion</title><p>In this work we investigated two common single nucleotide polymorphisms of <italic>XRCC1 </italic>gene Arg194Trp and Arg399Gln and their association with human head and neck squamous cell carcinoma. The genotype analysis of these two SNPs of <italic>XRCC1 </italic>gene, for 92 HNSCC patients and 124 controls of cancer free subjects, in Polish population were performed using PCR-RFLP method. The polymorphisms chosen for this study have been shown to have functional significance and may be responsible for a low DNA repair capacity phenotype characteristic of cancer patients including head and neck squamous carcinomas [<xref ref-type="bibr" rid="B29">29</xref>-<xref ref-type="bibr" rid="B32">32</xref>]. The characteristic of HNSCC patens group according to age, sex, tumor stage and smoking status data was displayed in table <xref ref-type="table" rid="T1">1</xref>.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>The characteristic of patients group with squamous cell carcinoma of the head and neck (HNSCC).</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center"><bold>Patients</bold></td><td align="center" colspan="2"><bold>Sex</bold></td><td align="center" colspan="10"><bold>Tumor stage</bold><break/><bold>(TNM)</bold></td><td align="center" colspan="4"><bold>Smoking status</bold><break/><bold>(cigarettes per day)</bold></td></tr></thead><tbody><tr><td align="center">No.</td><td align="center">men</td><td align="center">women</td><td align="center" colspan="4">T</td><td align="center" colspan="4">N</td><td align="center" colspan="2">M</td><td align="center">non</td><td align="center">10cc*</td><td align="center">20cc*</td><td align="center">20cc***</td></tr><tr><td></td><td></td><td></td><td colspan="10"><hr></hr></td><td></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td></td><td align="center">1</td><td align="center">2</td><td align="center">3</td><td align="center">4</td><td align="center">0</td><td align="center">1</td><td align="center">2</td><td align="center">3</td><td align="center">0</td><td align="center">1</td><td></td><td></td><td></td><td></td></tr><tr><td colspan="17"><hr></hr></td></tr><tr><td align="center">92</td><td align="center">83</td><td align="center">9</td><td align="center">15</td><td align="center">17</td><td align="center">31</td><td align="center">29</td><td align="center">62</td><td align="center">15</td><td align="center">10</td><td align="center">5</td><td align="center">92</td><td align="center">0</td><td align="center">26</td><td align="center">9</td><td align="center">33</td><td align="center">24</td></tr></tbody></table><table-wrap-foot><p>T (1&#x02013;4) &#x02013; size or direct extent of the primary tumor; N (0&#x02013;3) &#x02013; degree of spread to regional lymph nodes; M (0/1) &#x02013; presence of metastasis; non &#x02013; not smoking; * &#x02013; smoking for ten years; ** &#x02013; smoking for twenty years; *** &#x02013; smoking for thirty years.</p></table-wrap-foot></table-wrap><p>Genome integrity is maintained by an intricate network of DNA repair proteins [<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B34">34</xref>]. Organisms have developed several DNA-repair pathways as well as DNA-damage checkpoints. Defects in this complex machinery are associated with genotoxic susceptibility and familial predispositions to cancer [<xref ref-type="bibr" rid="B35">35</xref>]. Increasing evidence links environmental exposures, subtle modification in DNA repair efficiency, and cancer risk [<xref ref-type="bibr" rid="B36">36</xref>]. XRCC1 participates in DNA single strand break and base excision repair to protect genome stability in mammalian cells. One of the common polymorphisms of <italic>XRCC1 </italic>the Arg399Gln is located in the BRCT1 domain responsible for interacting with other repair components of BER. It was reported that Arg&#x02192;Gln substitution produces significant conformational changes at BRCT1 domain that may be critical for DNA repair protein-protein interactions [<xref ref-type="bibr" rid="B37">37</xref>], thus absence or impairment repair may cause genome instability and cancer occurrence. It is also important to integrate DNA-repair process with DNA-damage checkpoints and cell survival, to evaluate the role of DNA repair at both cellular and organismic levels. Therefore, protective effects of XRCC1 polymorphisms in cancer may also be observed by the enhanced efficiency of apoptosis at a cellular level as a result of diminished DNA repair capacity secondary to the genetic polymorphisms [<xref ref-type="bibr" rid="B38">38</xref>,<xref ref-type="bibr" rid="B39">39</xref>].</p><p>In our study, neither of these SNPs was found to individually contribute to head and neck cancer risk. There were no differences between the distribution of the genotypes or alleles frequences in patients and controls. However, we found statistically non-significant increase of Arg194Trp genotype frequency (OR, 1.37; 95% CI, 0.70&#x02013;2.68) and Trp<sup>194 </sup>allele (OR, 1.32; 95% CI, 0.70&#x02013;2.49) according to wild-type of Arg194Arg reference genotype and Arg<sup>194 </sup>allele frequency (table <xref ref-type="table" rid="T2">2</xref>). Non-statistical increase of Arg399Gln (OR, 1.10; 95% CI, 0.61&#x02013;1.97) according to reference genotype of Arg399Arg was also found. (table <xref ref-type="table" rid="T3">3</xref>). While, no altered risk has been found individually for the <italic>XRCC1 </italic>Arg194Trp or Arg399Gln polymorphisms, the halophyte analysis according to wild-type of Arg194Arg-Arg399Arg showed high association with head and neck cancer (table <xref ref-type="table" rid="T4">4</xref>). The findings indicated that a statistically non-significantly increased risk of HNSCC was associated with the combined Arg194Arg-Arg399Gln genotype (OR, 1.33; 95% CI, 0.70&#x02013;2.56). The higher risk of head and neck cancer occurrence was associated with the combined Arg194Trp-Arg399Arg genotype (OR, 2.96; 95% CI, 1.01&#x02013;8.80) but no altered risk was associated with others haplotypes. For Tyr165Tyr genotype we also observed positive correlation with cancer progression assessed by tumor size (OR 4.56; 95% CI 1.60&#x02013;12.95).</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Distribution of genotypes and frequency of alleles of the Arg/Trp 194 (C/T 26304 exon 6) polymorphism of <italic>XRCC1 </italic>gene in squamous cell carcinoma of the head and neck (HNSCC) patients and the controls.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center"><bold>Genotype Allele</bold></td><td align="center"><bold>HNSCC patients</bold><break/><bold>(n = 92)</bold><break/><bold>Number (frequency)</bold></td><td align="center"><bold>Controls</bold><break/><bold>(n = 124)</bold><break/><bold>Number (frequency)</bold></td><td align="center"><bold>OR (95% CI)</bold></td></tr></thead><tbody><tr><td align="center">Arg/Arg</td><td align="center">71 (0.86)</td><td align="center">102 (0.82)</td><td align="center">1 (reference)</td></tr><tr><td align="center">Arg/Trp</td><td align="center">21 (0.14)</td><td align="center">22 (0.18)</td><td align="center">1.37 (0.70; 2.68)</td></tr><tr><td align="center">Trp/Trp</td><td align="center">0 (0.00)</td><td align="center">0 (0.00)</td><td align="center">---------</td></tr><tr><td align="center">Arg</td><td align="center">163 (0.98)</td><td align="center">226 (0.91)</td><td align="center">1 (reference)</td></tr><tr><td align="center">Trp</td><td align="center">21 (0.12)</td><td align="center">22 (0.09)</td><td align="center">1.32 (0.70; 2.49)</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Distribution of genotypes and frequency of alleles of the Arg/Gln 399 (G/A 28152 exon 9) polymorphism of <italic>XRCC1 </italic>gene in squamous cell carcinoma of the head and neck (HNSCC) patients and the controls.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center"><bold>Genotype Allele</bold></td><td align="center"><bold>HNSCC patients</bold><break/><bold>(n = 92)</bold><break/><bold>Number (frequency)</bold></td><td align="center"><bold>Controls</bold><break/><bold>(n = 124)</bold><break/><bold>Number (frequency)</bold></td><td align="center"><bold>OR (95% CI)</bold></td></tr></thead><tbody><tr><td align="center">Arg/Arg</td><td align="center">37 (0,40)</td><td align="center">49 (0.40)</td><td align="center">1 (reference)</td></tr><tr><td align="center">Arg/Gln</td><td align="center">44 (0.48)</td><td align="center">53 (0.43)</td><td align="center">1.10 (0.61; 1.97)</td></tr><tr><td align="center">Gln/Gln</td><td align="center">11 (0.12)</td><td align="center">22 (0.18)</td><td align="center">0.66 (0.29; 1.53)</td></tr><tr><td align="center">Arg</td><td align="center">118 (0.64)</td><td align="center">151 (0.61)</td><td align="center">1 (reference)</td></tr><tr><td align="center">Gln</td><td align="center">66 (0.36)</td><td align="center">97 (0.39)</td><td align="center">0.87 (0.59; 1.29)</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Haplotypes distribution and frequencies of <italic>XRCC1 </italic>gene polymorphisms in squamous cell carcinoma of the head and neck (HNSCC) patients and the controls.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center"><bold>Haplotypes XRCC1-194&#x02013;399</bold></td><td align="center"><bold>HNSCC patients</bold><break/><bold>(n = 92)</bold><break/><bold>Number (frequency)</bold></td><td align="center"><bold>Controls</bold><break/><bold>(n = 124)</bold><break/><bold>Number (frequency)</bold></td><td align="center"><bold>OR (95% CI)</bold></td></tr></thead><tbody><tr><td align="center">Arg/Arg-Arg/Arg</td><td align="center">29 (0,32)</td><td align="center">43 (0,35)</td><td align="center">1 (reference)</td></tr><tr><td align="center">Arg/Trp-Arg/Arg</td><td align="center">12 (0.13)</td><td align="center">6 (0.05)</td><td align="center">2.96 (1.01; 8.80)</td></tr><tr><td align="center">Trp/Trp-Arg/Arg</td><td align="center">0 (0.00)</td><td align="center">0 (0.00)</td><td align="center">---------</td></tr><tr><td align="center">Arg/Arg-Arg/Gln</td><td align="center">36 (0.39)</td><td align="center">40 (0.32)</td><td align="center">1.33 (0.70; 2.56)</td></tr><tr><td align="center">Arg/Trp-Arg/Gln</td><td align="center">8 (0,09)</td><td align="center">13 (0,10)</td><td align="center">0.91 (0.34; 2.48)</td></tr><tr><td align="center">Trp/Trp-Arg/Gln</td><td align="center">0 (0.00)</td><td align="center">0 (0.00)</td><td align="center">---------</td></tr><tr><td align="center">Arg/Arg-Gln/Gln</td><td align="center">6 (0.07)</td><td align="center">19 (0.15)</td><td align="center">0.47 (0.17; 1.31)</td></tr><tr><td align="center">Arg/Trp-Gln/Gln</td><td align="center">1 (0.01)</td><td align="center">3 (0.02)</td><td align="center">0.49 (0.05; 4.99)</td></tr><tr><td align="center">Trp/Trp-Gln/Gln</td><td align="center">0 (0,00)</td><td align="center">0 (0,00)</td><td align="center">---------</td></tr></tbody></table></table-wrap><p>We also analyzed the distribution of genotypes and frequency of alleles in groups of patients suffer head and neck cancer according to different cancer staging by TNM classification (table <xref ref-type="table" rid="T5">5</xref> and table <xref ref-type="table" rid="T6">6</xref>). We did not find any association of the Arg194Tyr or Arg399Gln polymorphisms in patients group with cancer progression assessed by with tumour size (T) and node status (N). Additionally, as a high risk factor for head and neck cancer occurrence we analysed patients with positive smoking status within HNSCC group according to smokers selected from controls (table <xref ref-type="table" rid="T7">7</xref> and table <xref ref-type="table" rid="T8">8</xref>). While, no statistically significant differences in distribution of the Arg194Tyr genotype was calculated, we found statistically significant associations of Arg399Gln polymorphic variants of XRCC1 gene with cancer risk within smoking group of HNSCC patients. We found that Arg399Gln genotype frequency (OR, 2.70; 95% CI, 1.26&#x02013;5.78) and Gln<sup>399 </sup>allele (OR, 4.31; 95% CI, 2.29&#x02013;8.13) was associated with patients group smoked ten or more cigarettes per day for at least ten years. On the other hand Arg399Arg wild-type genotype (OR, 0.18; 95% CI, 0.08&#x02013;0.39) and Arg<sup>399 </sup>allele (OR, 0.22; 95% CI, 0.12&#x02013;0.41) had protective effect on cancer risk even in patients group with positive smoking status.</p><table-wrap position="float" id="T5"><label>Table 5</label><caption><p>The genotype and allele frequency and odds ratios (OR) of the Arg194Trp polymorphism of <italic>XRCC1 </italic>gene in patients with head and neck cancer with different tumor size and lymph node status.</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center" colspan="3"><bold>Tumour size (T)</bold></td><td align="center" colspan="3"><bold>Node status (N)</bold></td></tr><tr><td></td><td colspan="6"><hr></hr></td></tr><tr><td align="center"><bold>Genotype Allele</bold></td><td align="center">T3 + T4<break/>Number/Frequency</td><td align="center">T1+ T2<break/>Number/Frequency</td><td align="center">OR (95% CI)</td><td align="center">N1 + N2 + N3<break/>Number/Frequency</td><td align="center">N0<break/>Number/Frequency</td><td align="center">OR (95% CI)</td></tr></thead><tbody><tr><td align="center">Arg/Arg</td><td align="center">43 (0.72)</td><td align="center">28 (0.88)</td><td align="center">0.36 (0.11 &#x02013; 1.19)</td><td align="center">20 (0.67)</td><td align="center">51 (0.82)</td><td align="center">0.43 (0.16 &#x02013; 1.67)</td></tr><tr><td align="center">Arg/Trp</td><td align="center">17 (0.28)</td><td align="center">4 (0.12)</td><td align="center">2.76 (0.84 &#x02013; 9.08)</td><td align="center">10 (0.33)</td><td align="center">11 (0.18)</td><td align="center">2.32 (0.85 &#x02013; 6.30)</td></tr><tr><td align="center">Trp/Trp</td><td align="center">0 (0.00)</td><td align="center">0 (0.00)</td><td align="center">---------</td><td align="center">0 (0.00)</td><td align="center">0 (0.00)</td><td align="center">---------</td></tr><tr><td align="center">Arg</td><td align="center">103 (0.86)</td><td align="center">60 (0.96)</td><td align="center">0.40 (0.13 &#x02013; 1.27)</td><td align="center">50 (0.83)</td><td align="center">113 (0.91)</td><td align="center">0.48 (0.19 &#x02013; 1.32)</td></tr><tr><td align="center">Trp</td><td align="center">17 (0.14)</td><td align="center">4 (0.14)</td><td align="center">2.47 (0.80 &#x02013; 7.70)</td><td align="center">10 (0.17)</td><td align="center">11 (0.09)</td><td align="center">2.05 (0.82 &#x02013; 5.14)</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T6"><label>Table 6</label><caption><p>The genotype and allele frequency and odds ratios (OR) of the Arg399Gln polymorphism of <italic>XRCC1 </italic>gene in patients with head and neck cancer with different tumor size and lymph node status.</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center" colspan="3"><bold>Tumour size (T)</bold></td><td align="center" colspan="3"><bold>Node status (N)</bold></td></tr><tr><td></td><td colspan="6"><hr></hr></td></tr><tr><td align="center"><bold>Genotype Allele</bold></td><td align="center">T3 + T4<break/>Number/Frequency</td><td align="center">T1+ T2<break/>Number/Frequency</td><td align="center">OR (95% CI)</td><td align="center">N1 + N2 + N3<break/>Number/Frequency</td><td align="center">N0<break/>Number/Frequency</td><td align="center">OR (95% CI)</td></tr></thead><tbody><tr><td align="center">Arg/Arg</td><td align="center">24 (0.40)</td><td align="center">13 (0.41)</td><td align="center">0,97 (0.41 &#x02013; 2.34)</td><td align="center">8 (0,27)</td><td align="center">29 (0.47)</td><td align="center">0.41 (0.16 &#x02013; 1.07)</td></tr><tr><td align="center">Arg/Gln</td><td align="center">30 (0.50)</td><td align="center">14 (0.44)</td><td align="center">1.28 (0.54 &#x02013; 3.05)</td><td align="center">17 (0.57)</td><td align="center">27 (0.44)</td><td align="center">1.70 (0.70 &#x02013; 4.08)</td></tr><tr><td align="center">Gln/Gln</td><td align="center">6 (0.10)</td><td align="center">5 (0.16)</td><td align="center">0.60 (0.17 &#x02013; 2.14)</td><td align="center">5 (0.17)</td><td align="center">6 (0.10)</td><td align="center">1.86 (0.52 &#x02013; 6.70)</td></tr><tr><td align="center">Arg</td><td align="center">78 (0.65)</td><td align="center">40 (0.62)</td><td align="center">1.11 (0.59 &#x02013; 2.09)</td><td align="center">33 (0.55)</td><td align="center">85 (0.69)</td><td align="center">0.56 (0.30 &#x02013; 1.06)</td></tr><tr><td align="center">Gln</td><td align="center">42 (0.35)</td><td align="center">24 (0.38)</td><td align="center">0.89 (0.48 &#x02013; 1.68)</td><td align="center">27 (0.45)</td><td align="center">39 (0.31)</td><td align="center">1.78 (0.94 &#x02013; 3.36)</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T7"><label>Table 7</label><caption><p>The genotype and allele frequency and odds ratios (OR) of the Arg194Trp polymorphism of <italic>XRCC1 </italic>gene in squamous cell carcinoma of the head and neck (HNSCC) patients and the controls with positive smoking status.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center"><bold>Genotype Allele</bold></td><td align="center"><bold>HNSCC patients</bold><break/><bold>(n = 66)</bold><break/><bold>Number (frequency)</bold></td><td align="center"><bold>Controls</bold><break/><bold>(n = 52)</bold><break/><bold>Number (frequency)</bold></td><td align="center">OR (95% CI)</td></tr></thead><tbody><tr><td align="center">Arg/Arg</td><td align="center">49 (0.74)</td><td align="center">44 (0.85)</td><td align="center">0.52 (0.20 &#x02013; 1.33)</td></tr><tr><td align="center">Arg/Trp</td><td align="center">17 (0.26)</td><td align="center">8 (0.15)</td><td align="center">1.91 (0.75 &#x02013; 4.85)</td></tr><tr><td align="center">Trp/Trp</td><td align="center">0 (0.00)</td><td align="center">0 (0.00)</td><td align="center">---------</td></tr><tr><td align="center">Arg</td><td align="center">115 (0.87)</td><td align="center">96 (0.92)</td><td align="center">0.56 (0.23 &#x02013; 1.36)</td></tr><tr><td align="center">Trp</td><td align="center">17 (0.13)</td><td align="center">8 (0.08)</td><td align="center">1.77 (0.73 &#x02013; 4.28)</td></tr></tbody></table></table-wrap><table-wrap position="float" id="T8"><label>Table 8</label><caption><p>The genotype and allele frequency and odds ratios (OR) of the Arg399Gln polymorphism of <italic>XRCC1 </italic>gene in squamous cell carcinoma of the head and neck (HNSCC) patients and the controls with positive smoking status.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center"><bold>Genotype Allele</bold></td><td align="center"><bold>HNSCC patients</bold><break/><bold>(n = 66)</bold><break/><bold>Number (frequency)</bold></td><td align="center"><bold>Controls</bold><break/><bold>(n = 52)</bold><break/><bold>Number (frequency)</bold></td><td align="center">OR (95% CI)</td></tr></thead><tbody><tr><td align="center">Arg/Arg</td><td align="center">19 (0.29)</td><td align="center">36 (0.69)</td><td align="center">0.18 (0.08 &#x02013; 0.39)</td></tr><tr><td align="center">Arg/Gln</td><td align="center">36 (0.55)</td><td align="center">16 (0.31)</td><td align="center">2.70 (1.26 &#x02013; 5.78)</td></tr><tr><td align="center">Gln/Gln</td><td align="center">11 (0.16)</td><td align="center">0 (0.00)</td><td align="center">---------</td></tr><tr><td align="center">Arg</td><td align="center">74 (0.56)</td><td align="center">88 (0.85)</td><td align="center">0.22 (0.12 &#x02013; 0.41)</td></tr><tr><td align="center">Gln</td><td align="center">58 (0.44)</td><td align="center">16 (0.15)</td><td align="center">4.31 (2.29 &#x02013; 8.13)</td></tr></tbody></table></table-wrap><p>The <italic>XRCC1 </italic>gene polymorphisms have been extensively studied in the association with various human cancers mostly breast, lung or head and neck carcinomas. Major studies of head and neck cancer has been focused on polymorphisms of genes encoding enzymes of xenobiotic metabolism and DNA repair [<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B40">40</xref>]. Carriers of the <italic>XRCC1 </italic>Arg399Gln variant have been shown to have higher levels of DNA adducts [<xref ref-type="bibr" rid="B16">16</xref>] and to be at greater risk for ionizing radiation sensitivity [<xref ref-type="bibr" rid="B17">17</xref>] and tobacco correlated DNA damage [<xref ref-type="bibr" rid="B18">18</xref>-<xref ref-type="bibr" rid="B20">20</xref>]. Recently, Sreeja at al (2008) has shown that the carriers of <italic>XRCC1 </italic>Gln399Gln genotypes were at higher risk of lung cancer [<xref ref-type="bibr" rid="B12">12</xref>]. On the other hand, L&#x000f3;pez-Cima et al. (2007) has been reported that individuals homozygous for the <italic>XRCC1 </italic>Gln<sup>339 </sup>allele presented no risk of developing lung cancer [<xref ref-type="bibr" rid="B6">6</xref>]. The association between <italic>XRCC1 </italic>Arg399Gln polymorphism and ductal carcinoma of women with breast cancer was found statistically significant in studies performed by Dufloth et al. at 2008 [<xref ref-type="bibr" rid="B13">13</xref>]. Despite of large number of studies, in well-characterized populations, results from HNSCC patients are still confusing. There was a marginally significant risk of HNSCC observed in variants of <italic>XRCC1 </italic>genotype with Trp<sup>194 </sup>allele in Thailand population [<xref ref-type="bibr" rid="B41">41</xref>]. No altered risk was associated with the <italic>XRCC1 </italic>Arg399Gln genotype in Li et al. studies [<xref ref-type="bibr" rid="B42">42</xref>], however smokers carrying risk genotype of <italic>XRCC1 </italic>with dominant Gln<sup>399 </sup>allele were over-represented in head and neck cancer populations from eastern region of India [<xref ref-type="bibr" rid="B43">43</xref>]. Recently, combinational polymorphisms of four DNA repair genes <italic>XRCC1, XRCC2, XRCC3</italic>, and <italic>XRCC4 </italic>and their association with HNSCC cancer in Taiwan has been investigated. [<xref ref-type="bibr" rid="B14">14</xref>]. Except for <italic>XRCC2</italic>, none of SNPs was found to individually contribute to cancer risk. In our study, we found that Gln<sup>399 </sup>allele may also increase head and neck cancer risk in population with positive smoking status. Finally, no association was found individually for either analyzed SNPs but we evidenced that combined genotypes of <italic>XRCC1 </italic>may have impact on HNSCC risk.</p></sec><sec><title>Conclusion</title><p>Head and neck cancer patients have variable prognoses even within the same clinical stage and while receiving similar treatments. The number of studies of genetic polymorphisms as prognostic factors of HNSCC outcomes is growing. Candidate polymorphisms have been evaluated in DNA repair, cell cycle, xenobiotic metabolism, and growth factor pathways. In our study, we assessed two common polymorphisms of the <italic>XRCC1 </italic>gene that might influence DNA repair capacity and their association with head and neck cancer risk. Finally, we identified the combined genotype of Arg194Trp-Arg399Arg that was associated with HNSCC cancer risk and may have an impact on identification of a high-risk population.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>MK have made substantial contributions to conception, design and drafting the manuscript. KP, PR, WP, AB-K and JS have made acquisition of data, analysis and interpretation of data. WM, JO, AM-S have made substantial contributions to patients sample collection. IM has made substantial contributions to conception and design, acquisition of data, analysis and interpretation of data, drafting the manuscript and revising it critically for important intellectual content. He has also given final approval of the version to be published.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>This work was supported by grant N301 099 32/3581 from Polish Ministry of Science and Higher Education.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lindahl</surname><given-names>T</given-names></name><name><surname>Wood</surname><given-names>RD</given-names></name></person-group><article-title>Quality control by DNA repair</article-title><source>Science</source><year>1999</year><volume>286</volume><fpage>1897</fpage><lpage>1905</lpage><pub-id pub-id-type="pmid">10583946</pub-id><pub-id pub-id-type="doi">10.1126/science.286.5446.1897</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoeijmakers</surname><given-names>JH</given-names></name></person-group><article-title>Genome maintenance mechanisms for preventing cancer</article-title><source>Nature</source><year>2001</year><volume>411</volume><fpage>366</fpage><lpage>374</lpage><pub-id pub-id-type="pmid">11357144</pub-id><pub-id pub-id-type="doi">10.1038/35077232</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barnes</surname><given-names>DE</given-names></name><name><surname>Lindahl</surname><given-names>T</given-names></name></person-group><article-title>Repair and genetic consequences of endogenous DNA base damage in mammalian cells</article-title><source>Annu Rev Genet</source><year>2004</year><volume>38</volume><fpage>445</fpage><lpage>476</lpage><pub-id pub-id-type="pmid">15568983</pub-id><pub-id pub-id-type="doi">10.1146/annurev.genet.38.072902.092448</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vogelstein</surname><given-names>B</given-names></name><name><surname>Kinzler</surname><given-names>KW</given-names></name></person-group><article-title>Cancer genes and the pathways they control</article-title><source>Nat Med</source><year>2004</year><volume>10</volume><fpage>789</fpage><lpage>799</lpage><pub-id pub-id-type="pmid">15286780</pub-id><pub-id pub-id-type="doi">10.1038/nm1087</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mohrenweiser</surname><given-names>HW</given-names></name><name><surname>Wilson</surname><given-names>DM</given-names><suffix>III</suffix></name><name><surname>Jones</surname><given-names>IM</given-names></name></person-group><article-title>Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes</article-title><source>Mutat Res</source><year>2003</year><volume>526</volume><fpage>93</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">12714187</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>L&#x000f3;pez-Cima</surname><given-names>MF</given-names></name><name><surname>Gonz&#x000e1;lez-Arriaga</surname><given-names>P</given-names></name><name><surname>Garc&#x000ed;a-Castro</surname><given-names>L</given-names></name><name><surname>Pascual</surname><given-names>T</given-names></name><name><surname>Marr&#x000f3;n</surname><given-names>MG</given-names></name><name><surname>Puente</surname><given-names>XS</given-names></name><name><surname>Tard&#x000f3;n</surname><given-names>A</given-names></name></person-group><article-title>Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain</article-title><source>BMC Cancer</source><year>2007</year><volume>7</volume><fpage>162</fpage><pub-id pub-id-type="pmid">17705814</pub-id><pub-id pub-id-type="doi">10.1186/1471-2407-7-162</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martinez-Balibrea</surname><given-names>E</given-names></name><name><surname>Manzano</surname><given-names>JL</given-names></name><name><surname>Martinez-Cardus</surname><given-names>A</given-names></name><name><surname>Moran</surname><given-names>T</given-names></name><name><surname>Cirauqui</surname><given-names>B</given-names></name><name><surname>Catot</surname><given-names>S</given-names></name><name><surname>Taron</surname><given-names>M</given-names></name><name><surname>Abad</surname><given-names>A</given-names></name></person-group><article-title>Combined analysis of genetic polymorphisms in thymidylate synthase, uridine diphosphate glucoronosyltransferase and X-ray cross complementing factor 1 genes as a prognostic factor in advanced colorectal cancer patients treated with 5-fluorouracil plus oxaliplatin or irinotecan</article-title><source>Oncol Rep</source><year>2007</year><volume>17</volume><issue>3</issue><fpage>637</fpage><lpage>645</lpage><pub-id pub-id-type="pmid">17273745</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burri</surname><given-names>RJ</given-names></name><name><surname>Stock</surname><given-names>RG</given-names></name><name><surname>Cesaretti</surname><given-names>JA</given-names></name><name><surname>Atencio</surname><given-names>DP</given-names></name><name><surname>Peters</surname><given-names>S</given-names></name><name><surname>Peters</surname><given-names>CA</given-names></name><name><surname>Fan</surname><given-names>G</given-names></name><name><surname>Stone</surname><given-names>NN</given-names></name><name><surname>Ostrer</surname><given-names>H</given-names></name><name><surname>Rosenstein</surname><given-names>BS</given-names></name></person-group><article-title>Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer</article-title><source>Radiat Res</source><year>2008</year><volume>170</volume><issue>1</issue><fpage>49</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">18582155</pub-id><pub-id pub-id-type="doi">10.1667/RR1219.1</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McWilliams</surname><given-names>RR</given-names></name><name><surname>Bamlet</surname><given-names>WR</given-names></name><name><surname>Cunningham</surname><given-names>JM</given-names></name><name><surname>Goode</surname><given-names>EL</given-names></name><name><surname>de Andrade</surname><given-names>M</given-names></name><name><surname>Boardman</surname><given-names>LA</given-names></name><name><surname>Petersen</surname><given-names>GM</given-names></name></person-group><article-title>Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk</article-title><source>Cancer Res</source><year>2008</year><volume>15;68</volume><issue>12</issue><fpage>4928</fpage><lpage>4935</lpage><pub-id pub-id-type="pmid">18544627</pub-id><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-5539</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fontana</surname><given-names>L</given-names></name><name><surname>Bosviel</surname><given-names>R</given-names></name><name><surname>Delort</surname><given-names>L</given-names></name><name><surname>Guy</surname><given-names>L</given-names></name><name><surname>Chalabi</surname><given-names>N</given-names></name><name><surname>Kwiatkowski</surname><given-names>F</given-names></name><name><surname>Satih</surname><given-names>S</given-names></name><name><surname>Rabiau</surname><given-names>N</given-names></name><name><surname>Boiteux</surname><given-names>JP</given-names></name><name><surname>Chamoux</surname><given-names>A</given-names></name><name><surname>Bignon</surname><given-names>YJ</given-names></name><name><surname>Bernard-Gallon</surname><given-names>DJ</given-names></name></person-group><article-title>DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort</article-title><source>Anticancer Res</source><year>2008</year><volume>28</volume><issue>3B</issue><fpage>1853</fpage><lpage>1856</lpage><pub-id pub-id-type="pmid">18630471</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>B</given-names></name><name><surname>Lin</surname><given-names>D</given-names></name><name><surname>Tan</surname><given-names>W</given-names></name><name><surname>Leaw</surname><given-names>S</given-names></name><name><surname>Hong</surname><given-names>X</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name></person-group><article-title>XRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population</article-title><source>Lung Cancer</source><year>2008</year><volume>62</volume><issue>1</issue><fpage>99</fpage><lpage>104</lpage><pub-id pub-id-type="pmid">18400332</pub-id><pub-id pub-id-type="doi">10.1016/j.lungcan.2008.02.019</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sreeja</surname><given-names>L</given-names></name><name><surname>Syamala</surname><given-names>VS</given-names></name><name><surname>Syamala</surname><given-names>V</given-names></name><name><surname>Hariharan</surname><given-names>S</given-names></name><name><surname>Raveendran</surname><given-names>PB</given-names></name><name><surname>Vijayalekshmi</surname><given-names>RV</given-names></name><name><surname>Madhavan</surname><given-names>J</given-names></name><name><surname>Ankathil</surname><given-names>R</given-names></name></person-group><article-title>Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India</article-title><source>J Cancer Res Clin Oncol</source><year>2008</year><volume>134</volume><issue>6</issue><fpage>645</fpage><lpage>652</lpage><pub-id pub-id-type="pmid">17952468</pub-id><pub-id pub-id-type="doi">10.1007/s00432-007-0328-4</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dufloth</surname><given-names>RM</given-names></name><name><surname>Arruda</surname><given-names>A</given-names></name><name><surname>Heinrich</surname><given-names>JK</given-names></name><name><surname>Schmitt</surname><given-names>F</given-names></name><name><surname>Zeferino</surname><given-names>LC</given-names></name></person-group><article-title>The investigation of DNA repair polymorphisms with histopathological characteristics and hormone receptors in a group of Brazilian women with breast cancer</article-title><source>Genet Mol Res</source><year>2008</year><volume>1;7</volume><issue>3</issue><fpage>574</fpage><lpage>582</lpage><pub-id pub-id-type="pmid">18752184</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yen</surname><given-names>CY</given-names></name><name><surname>Liu</surname><given-names>SY</given-names></name><name><surname>Chen</surname><given-names>CH</given-names></name><name><surname>Tseng</surname><given-names>HF</given-names></name><name><surname>Chuang</surname><given-names>LY</given-names></name><name><surname>Yang</surname><given-names>CH</given-names></name><name><surname>Lin</surname><given-names>YC</given-names></name><name><surname>Wen</surname><given-names>CH</given-names></name><name><surname>Chiang</surname><given-names>WF</given-names></name><name><surname>Ho</surname><given-names>CH</given-names></name><name><surname>Chen</surname><given-names>HC</given-names></name><name><surname>Wang</surname><given-names>ST</given-names></name><name><surname>Lin</surname><given-names>CW</given-names></name><name><surname>Chang</surname><given-names>HW</given-names></name></person-group><article-title>Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan</article-title><source>J Oral Pathol Med</source><year>2008</year><volume>37</volume><issue>5</issue><fpage>271</fpage><lpage>277</lpage><pub-id pub-id-type="pmid">18410587</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shall</surname><given-names>S</given-names></name><name><surname>de Murcia</surname><given-names>G</given-names></name></person-group><article-title>Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model?</article-title><source>Mutat Res</source><year>2000</year><volume>460</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">10856830</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lunn</surname><given-names>RM</given-names></name><name><surname>Langlois</surname><given-names>RG</given-names></name><name><surname>Hsieh</surname><given-names>LL</given-names></name><name><surname>Thompson</surname><given-names>CL</given-names></name><name><surname>Bell</surname><given-names>DA</given-names></name></person-group><article-title><italic>XRCC1 </italic>polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency</article-title><source>Cancer Res</source><year>1999</year><volume>59</volume><fpage>2557</fpage><lpage>2561</lpage><pub-id pub-id-type="pmid">10363972</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>JJ</given-names></name><name><surname>Smith</surname><given-names>TR</given-names></name><name><surname>Miller</surname><given-names>MS</given-names></name></person-group><article-title>Amino acid substitution variants of APE1 and <italic>XRCC1 </italic>genes associated with ionizing radiation sensitivity</article-title><source>Carcinogenesis</source><year>2001</year><volume>22</volume><fpage>917</fpage><lpage>922</lpage><pub-id pub-id-type="pmid">11375899</pub-id><pub-id pub-id-type="doi">10.1093/carcin/22.6.917</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duell</surname><given-names>EJ</given-names></name><name><surname>Wiencke</surname><given-names>JK</given-names></name><name><surname>Cheng</surname><given-names>TJ</given-names></name><name><surname>Varkonyi</surname><given-names>A</given-names></name><name><surname>Zuo</surname><given-names>ZF</given-names></name><name><surname>Ashok</surname><given-names>TD</given-names></name><name><surname>Mark</surname><given-names>EJ</given-names></name><name><surname>Wain</surname><given-names>JC</given-names></name><name><surname>Christiani</surname><given-names>DC</given-names></name><name><surname>Kelsey</surname><given-names>KT</given-names></name></person-group><article-title>Polymorphisms in the DNA repair genes <italic>XRCC1 </italic>and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells</article-title><source>Carcinogenesis</source><year>2000</year><volume>21</volume><fpage>965</fpage><lpage>971</lpage><pub-id pub-id-type="pmid">10783319</pub-id><pub-id pub-id-type="doi">10.1093/carcin/21.5.965</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abdel-Rahman</surname><given-names>SZ</given-names></name><name><surname>El Zein</surname><given-names>RA</given-names></name></person-group><article-title>The 399Gln polymorphism in the DNA repair gene <italic>XRCC1 </italic>modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine NNK</article-title><source>Cancer Lett</source><year>2000</year><volume>159</volume><fpage>63</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">10974407</pub-id><pub-id pub-id-type="doi">10.1016/S0304-3835(00)00532-2</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>YC</given-names></name><name><surname>Hwang</surname><given-names>SJ</given-names></name><name><surname>Chang</surname><given-names>CC</given-names></name><name><surname>Kuo</surname><given-names>HW</given-names></name><name><surname>Luo</surname><given-names>JC</given-names></name><name><surname>Chang</surname><given-names>MJ</given-names></name><name><surname>Cheng</surname><given-names>TJ</given-names></name></person-group><article-title>Effects on sister chromatid exchange frequency of polymorphisms in DNA repair gene <italic>XRCC1 </italic>in smokers</article-title><source>Mutat Res</source><year>2002</year><volume>519</volume><fpage>93</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">12160895</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kubota</surname><given-names>Y</given-names></name><name><surname>Nash</surname><given-names>RA</given-names></name><name><surname>Klungland</surname><given-names>A</given-names></name><name><surname>Schar</surname><given-names>P</given-names></name><name><surname>Barnes</surname><given-names>DE</given-names></name><name><surname>Lindahl</surname><given-names>T</given-names></name></person-group><article-title>Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the <italic>XRCC1 </italic>protein</article-title><source>EMBO J</source><year>1996</year><volume>15</volume><fpage>6662</fpage><lpage>6670</lpage><pub-id pub-id-type="pmid">8978692</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caldecott</surname><given-names>KW</given-names></name></person-group><article-title><italic>XRCC1 </italic>and DNA strand break repair</article-title><source>DNA Repair</source><year>2003</year><volume>2</volume><fpage>955</fpage><lpage>969</lpage><pub-id pub-id-type="pmid">12967653</pub-id><pub-id pub-id-type="doi">10.1016/S1568-7864(03)00118-6</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marsin</surname><given-names>S</given-names></name><name><surname>Vidal</surname><given-names>AE</given-names></name><name><surname>Sossou</surname><given-names>M</given-names></name><name><surname>M&#x000e9;nissier-de Murcia</surname><given-names>J</given-names></name><name><surname>Le Page</surname><given-names>F</given-names></name><name><surname>Boiteux</surname><given-names>S</given-names></name><name><surname>de Murcia</surname><given-names>G</given-names></name><name><surname>Radicella</surname><given-names>JP</given-names></name></person-group><article-title>Role of XRCC1 in the coordination and stimulation of oxidative DNA damage repair initiated by the DNA glycosylase hOGG1</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><issue>45</issue><fpage>44068</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">12933815</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M306160200</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campalans</surname><given-names>A</given-names></name><name><surname>Marsin</surname><given-names>S</given-names></name><name><surname>Nakabeppu</surname><given-names>Y</given-names></name><name><surname>O'connor</surname><given-names>TR</given-names></name><name><surname>Boiteux</surname><given-names>S</given-names></name><name><surname>Radicella</surname><given-names>JP</given-names></name></person-group><article-title>XRCC1 interactions with multiple DNA glycosylases: a model for its recruitment to base excision repair</article-title><source>DNA Repair (Amst)</source><year>2005</year><volume>4</volume><issue>7</issue><fpage>826</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">15927541</pub-id><pub-id pub-id-type="doi">10.1016/j.dnarep.2005.04.014</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nazarkina</surname><given-names>ZK</given-names></name><name><surname>Khodyreva</surname><given-names>SN</given-names></name><name><surname>Marsin</surname><given-names>S</given-names></name><name><surname>Lavrik</surname><given-names>OI</given-names></name><name><surname>Radicella</surname><given-names>JP</given-names></name></person-group><article-title>XRCC1 interactions with base excision repair DNA intermediates</article-title><source>DNA Repair (Amst)</source><year>2007</year><volume>6</volume><issue>2</issue><fpage>254</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">17118717</pub-id><pub-id pub-id-type="doi">10.1016/j.dnarep.2006.10.002</pub-id></citation></ref><ref id="B26"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Koskinen</surname><given-names>WJ</given-names></name></person-group><article-title>Prognostic markers in head and neck carcinoma</article-title><source>Academic Dissertation</source><year>2006</year><publisher-name>Haartman Institute, Helsinki</publisher-name><fpage>21</fpage><lpage>27</lpage></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Miller</surname><given-names>DP</given-names></name><name><surname>Thurston</surname><given-names>SW</given-names></name><name><surname>Li Lian</surname><given-names>X</given-names></name><name><surname>Wain</surname><given-names>JC</given-names></name><name><surname>Lynch</surname><given-names>TJ</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Christiani</surname><given-names>DC</given-names></name></person-group><article-title>Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer</article-title><source>Cancer Res</source><year>2002</year><volume>62</volume><fpage>1377</fpage><lpage>1381</lpage><pub-id pub-id-type="pmid">11888908</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stern</surname><given-names>MC</given-names></name><name><surname>Siegmund</surname><given-names>KD</given-names></name><name><surname>Corral</surname><given-names>R</given-names></name><name><surname>Haile</surname><given-names>RW</given-names></name></person-group><article-title>XRCC1 and XRCC3 Polymorphisms and Their Role as Effect Modifiers of Unsaturated Fatty Acids and Antioxidant Intake on Colorectal Adenomas Risk</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2005</year><volume>14</volume><issue>3</issue><fpage>609</fpage><lpage>615</lpage><pub-id pub-id-type="pmid">15767338</pub-id><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-04-0189</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Helzlsouer</surname><given-names>KJ</given-names></name><name><surname>Harris</surname><given-names>EL</given-names></name><name><surname>Parshad</surname><given-names>R</given-names></name><name><surname>Perry</surname><given-names>HR</given-names></name><name><surname>Price</surname><given-names>FM</given-names></name><name><surname>Sanford</surname><given-names>KK</given-names></name></person-group><article-title>DNA repair proficiency: potential susceptiblity factor for breast cancer</article-title><source>J Natl Cancer Inst</source><year>1996</year><volume>88</volume><fpage>754</fpage><lpage>755</lpage><pub-id pub-id-type="pmid">8637030</pub-id><pub-id pub-id-type="doi">10.1093/jnci/88.11.754</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>Q</given-names></name><name><surname>Spitz</surname><given-names>MR</given-names></name></person-group><article-title>The role of DNA repair capacity in susceptibility to lung cancer: a review</article-title><source>Cancer Metastasis Rev</source><year>1997</year><volume>16</volume><fpage>295</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">9433641</pub-id><pub-id pub-id-type="doi">10.1023/A:1005852211430</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hopkins</surname><given-names>J</given-names></name><name><surname>Cescon</surname><given-names>DW</given-names></name><name><surname>Tse</surname><given-names>D</given-names></name><name><surname>Bradbury</surname><given-names>P</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Ma</surname><given-names>C</given-names></name><name><surname>Wheatley-Price</surname><given-names>P</given-names></name><name><surname>Waldron</surname><given-names>J</given-names></name><name><surname>Goldstein</surname><given-names>D</given-names></name><name><surname>Meyer</surname><given-names>F</given-names></name><name><surname>Bairati</surname><given-names>I</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name></person-group><article-title>Genetic polymorphisms and head and neck cancer outcomes: a review</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2008</year><volume>17</volume><fpage>490</fpage><lpage>499</lpage><pub-id pub-id-type="pmid">18349267</pub-id><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-07-2714</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hiyama</surname><given-names>T</given-names></name><name><surname>Yoshihara</surname><given-names>M</given-names></name><name><surname>Tanaka</surname><given-names>S</given-names></name><name><surname>Chayama</surname><given-names>K</given-names></name></person-group><article-title>Genetic polymorphisms and head and neck cancer risk (Review)</article-title><source>Int J Oncol</source><year>2008</year><volume>32</volume><fpage>945</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">18425322</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lindahl</surname><given-names>T</given-names></name></person-group><article-title>Keynote: past, present, and future aspects of base excision repair</article-title><source> Prog Nucleic Acid Res Mol Biol</source><year>2001</year><volume>68</volume><fpage>17</fpage><lpage>30</lpage></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoeijmakers</surname><given-names>JH</given-names></name></person-group><article-title>Genome maintenance mechanisms for preventing cancer</article-title><source>Nature</source><year>2001</year><volume>411</volume><fpage>366</fpage><lpage>374</lpage><pub-id pub-id-type="pmid">11357144</pub-id><pub-id pub-id-type="doi">10.1038/35077232</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bohr</surname><given-names>VA</given-names></name></person-group><article-title>DNA damage and its processing: relation to human disease</article-title><source>J Inherit Metab Dis</source><year>2002</year><volume>25</volume><fpage>215</fpage><lpage>222</lpage><pub-id pub-id-type="pmid">12137230</pub-id><pub-id pub-id-type="doi">10.1023/A:1015681929316</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mohrenweiser</surname><given-names>HW</given-names></name><name><surname>Wilson</surname><given-names>DM</given-names><suffix>III</suffix></name><name><surname>Jones</surname><given-names>IM</given-names></name></person-group><article-title>Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes</article-title><source>Mutat Res</source><year>2003</year><volume>526</volume><fpage>93</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">12714187</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monaco</surname><given-names>R</given-names></name><name><surname>Rosal</surname><given-names>R</given-names></name><name><surname>Dolan</surname><given-names>MA</given-names></name><name><surname>Pincus</surname><given-names>MR</given-names></name><name><surname>Brandt-Rauf</surname><given-names>PW</given-names></name></person-group><article-title>Conformational effects of a common codon 399 polymorphism on the BRCT1 domain of the XRCC1 protein</article-title><source>Protein J</source><year>2007</year><volume>26</volume><issue>8</issue><fpage>541</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">17899335</pub-id><pub-id pub-id-type="doi">10.1007/s10930-007-9095-y</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Olshan</surname><given-names>AF</given-names></name><name><surname>Watson</surname><given-names>MA</given-names></name><name><surname>Weissler</surname><given-names>MC</given-names></name><name><surname>Bell</surname><given-names>DA</given-names></name></person-group><article-title>XRCC1 polymorphisms and head and neck cancer</article-title><source>Cancer Lett</source><year>2002</year><volume>178</volume><issue>2</issue><fpage>181</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11867203</pub-id><pub-id pub-id-type="doi">10.1016/S0304-3835(01)00822-9</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>HH</given-names></name><name><surname>Kelsey</surname><given-names>KT</given-names></name><name><surname>Mott</surname><given-names>LA</given-names></name><name><surname>Karagas</surname><given-names>MR</given-names></name></person-group><article-title>The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene-environment interaction</article-title><source>Cancer Res</source><year>2002</year><volume>62</volume><issue>1</issue><fpage>152</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">11782372</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harth</surname><given-names>V</given-names></name><name><surname>Schafer</surname><given-names>M</given-names></name><name><surname>Abel</surname><given-names>J</given-names></name><name><surname>Maintz</surname><given-names>L</given-names></name><name><surname>Neuhaus</surname><given-names>T</given-names></name><name><surname>Besuden</surname><given-names>M</given-names></name><name><surname>Primke</surname><given-names>R</given-names></name><name><surname>Wilkesmann</surname><given-names>A</given-names></name><name><surname>Thier</surname><given-names>R</given-names></name><name><surname>Vetter</surname><given-names>H</given-names></name><name><surname>Ko</surname><given-names>YD</given-names></name><name><surname>Bruning</surname><given-names>T</given-names></name><name><surname>Bolt</surname><given-names>HM</given-names></name><name><surname>Ickstadt</surname><given-names>K</given-names></name></person-group><article-title>Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair</article-title><source>J Toxicol Environ Health A</source><year>2008</year><volume>71</volume><fpage>887</fpage><lpage>897</lpage><pub-id pub-id-type="pmid">18569591</pub-id><pub-id pub-id-type="doi">10.1080/15287390801988160</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kietthubthew</surname><given-names>S</given-names></name><name><surname>Sriplung</surname><given-names>H</given-names></name><name><surname>Au</surname><given-names>WW</given-names></name><name><surname>Ishida</surname><given-names>T</given-names></name></person-group><article-title>Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand</article-title><source>Int J Hyg Environ Health</source><year>2006</year><volume>209</volume><issue>1</issue><fpage>21</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">16373199</pub-id><pub-id pub-id-type="doi">10.1016/j.ijheh.2005.06.002</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Hu</surname><given-names>Z</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>LE</given-names></name><name><surname>El-Naggar</surname><given-names>AK</given-names></name><name><surname>Sturgis</surname><given-names>EM</given-names></name><name><surname>Spitz</surname><given-names>MR</given-names></name><name><surname>Wei</surname><given-names>Q</given-names></name></person-group><article-title>Genetic polymorphisms in DNA base-excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck</article-title><source>Cancer</source><year>2007</year><volume>15;110</volume><issue>4</issue><fpage>867</fpage><lpage>875</lpage><pub-id pub-id-type="pmid">17614107</pub-id><pub-id pub-id-type="doi">10.1002/cncr.22861</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Majumder</surname><given-names>M</given-names></name><name><surname>Sikdar</surname><given-names>N</given-names></name><name><surname>Paul</surname><given-names>RR</given-names></name><name><surname>Roy</surname><given-names>B</given-names></name></person-group><article-title>Increased risk of oral leukoplakia and cancer among mixed tobacco users carrying XRCC1 variant haplotypes and cancer among smokers carrying two risk genotypes: one on each of two loci, GSTM3 and XRCC1 (Codon 280)</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2005</year><volume>14</volume><issue>9</issue><fpage>2106</fpage><lpage>2112</lpage><pub-id pub-id-type="pmid">16172217</pub-id><pub-id pub-id-type="doi">10.1158/1055-9965.EPI-05-0108</pub-id></citation></ref></ref-list></back></article> 